Bernard Devauchelle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bernard Devauchelle has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
S. Testelin
Service CMF, CHU Amiens Picardie, rond point du professeur Cabrol, 80000 Amiens, France; Unité de recherche 7516 CHIMERE - université de Picardie Jules Verne, chemin du Thill, 80000 Amiens Picardie, France; Institut Faire-Faces, place Cabrol, Amiens Picardie, France
13 shared publicationsS Testelin
7 shared publications- C. Moure
Service de chirurgie maxillofaciale, CHU de Amiens-Nord, place Victor-Pauchet, 80000 Amiens, France
5 shared publications - S. Dakpe
Service de chirurgie maxillofaciale et stomatologie, CHU d'Amiens, place Victor-Pauchet, 80000 Amiens, France; Institut Faire Faces, CHU d'Amiens, place Victor-Pauchet, 80000 Amiens, France
5 shared publications - Stéphanie Dakpé
Department of Maxillofacial Surgery, University Hospital of Amiens-Picardy, Avenue René Laennec, 80000, Amiens, France
5 shared publications - Sylvie Testelin
Centre Hospitalier Universitaire Amiens-Picardie, Rond-Point du Pr Christian Cabrol, 80054 Amiens, France
5 shared publications
Latest Publications
- Open Access
- 22 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (8) , 2439
Impact of the COVID-19 Pandemic on Head and Neck Cancer Management: The Experience of the Maxillo-Facial Surgery Department of a French Regional Referral Center in a High-Incidence Area
Background: Cancer patients are at a high risk of complications in cases of infection, and head and neck cancers (HNC) are no exception. Since late 2019, SARS-CoV-2 has caused a global health crisis, with high rates and severe forms of the disease in cancer patients. Hospitalization, surgery and radiotherapy were rapidly described as increasing the risk of infection. Since March 2020, the Amiens University Hospital (France) has been taking care of COVID-19 patients while its maxillofacial surgery department managed HNC patients without interruption, even during lockdown periods. However, many questions concerning the impact on patient care were still pending. The aim of this study is to describe HNC management in our center during the first epidemic peak and to evaluate the impact of containment measures on patient treatment. Methods: We retrospectively included 44 HNC patients treated in our department between 1 March and 31 August 2020. Two groups were defined according to the period of care: lockdown (March to May) and lighter restrictions (June to August). Results: The results show typical epidemiological characteristics, maintained management times and non-downgraded procedures. Conclusions: Thus, during the first epidemic peak, continuity of care and patients’ safety could be ensured thanks to adequate means, adapted procedures and an experienced surgical team.
- 22 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (8) , 2439
Open AccessImpact of the COVID-19 Pandemic on Head and Neck Cancer Management: The Experience of the Maxillo-Facial Surgery Department of a French Regional Referral Center in a High-Incidence Area
Background: Cancer patients are at a high risk of complications in cases of infection, and head and neck cancers (HNC) are no exception. Since late 2019, SARS-CoV-2 has caused a global health crisis, with high rates and severe forms of the disease in cancer patients. Hospitalization, surgery and radiotherapy were rapidly described as increasing the risk of infection. Since March 2020, the Amiens University Hospital (France) has been taking care of COVID-19 patients while its maxillofacial surgery department managed HNC patients without interruption, even during lockdown periods. However, many questions concerning the impact on patient care were still pending. The aim of this study is to describe HNC management in our center during the first epidemic peak and to evaluate the impact of containment measures on patient treatment. Methods: We retrospectively included 44 HNC patients treated in our department between 1 March and 31 August 2020. Two groups were defined according to the period of care: lockdown (March to May) and lighter restrictions (June to August). Results: The results show typical epidemiological characteristics, maintained management times and non-downgraded procedures. Conclusions: Thus, during the first epidemic peak, continuity of care and patients’ safety could be ensured thanks to adequate means, adapted procedures and an experienced surgical team.
- Open Access
- 2 September 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (9) , 1035
Evaluation of a Granular Bone Substitute for Bone Regeneration Using an Optimized In Vivo Alveolar Cleft Model
Alveolar cleft is a common congenital deformity that requires surgical intervention, notably using autologous bone grafts in young children. Bone substitutes, in combination with mesenchymal stem cells (MSCs), have shown promise in the repair of these defects. This study aimed to evaluate the regenerative capabilities of a granular bone substitute using an optimized alveolar cleft model. Thirty-six rats underwent a surgical procedure for the creation of a defect filled with a fragment of silicone. After 5 weeks, the silicone was removed and the biomaterial, with or without Wharton’s jelly MSCs, was put into the defect, except for the control group. The rats underwent μCT scans immediately and after 4 and 8 weeks. Analyses showed a statistically significant improvement in bone regeneration in the two treatment groups compared with control at weeks 4 and 8, both for bone volume (94.64% ± 10.71% and 91.33% ± 13.30%, vs. 76.09% ± 7.99%) and mineral density (96.13% ± 24.19% and 93.01% ± 27.04%, vs. 51.64% ± 16.51%), but without having fully healed. This study validates our optimized alveolar cleft model in rats, but further work is needed to allow for the use of this granular bone substitute in the treatment of bone defects.
- 2 September 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (9) , 1035
Open AccessEvaluation of a Granular Bone Substitute for Bone Regeneration Using an Optimized In Vivo Alveolar Cleft Model
Alveolar cleft is a common congenital deformity that requires surgical intervention, notably using autologous bone grafts in young children. Bone substitutes, in combination with mesenchymal stem cells (MSCs), have shown promise in the repair of these defects. This study aimed to evaluate the regenerative capabilities of a granular bone substitute using an optimized alveolar cleft model. Thirty-six rats underwent a surgical procedure for the creation of a defect filled with a fragment of silicone. After 5 weeks, the silicone was removed and the biomaterial, with or without Wharton’s jelly MSCs, was put into the defect, except for the control group. The rats underwent μCT scans immediately and after 4 and 8 weeks. Analyses showed a statistically significant improvement in bone regeneration in the two treatment groups compared with control at weeks 4 and 8, both for bone volume (94.64% ± 10.71% and 91.33% ± 13.30%, vs. 76.09% ± 7.99%) and mineral density (96.13% ± 24.19% and 93.01% ± 27.04%, vs. 51.64% ± 16.51%), but without having fully healed. This study validates our optimized alveolar cleft model in rats, but further work is needed to allow for the use of this granular bone substitute in the treatment of bone defects.
- 24 February 2023
- Published by Springer Nature
- p. 67-72
Facial Allotransplantation: Outcomes and Results of the Amiens/Lyon Team
- 24 February 2023
- Published by Springer Nature
- p. 67-72
Facial Allotransplantation: Outcomes and Results of the Amiens/Lyon Team
- 1 June 2021
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 66 (3) , 193-200
L’Odyssée de l’iliaque. « De la reconstruction mandibulaire par autotransplantation »
- 1 June 2021
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 66 (3) , 193-200
L’Odyssée de l’iliaque. « De la reconstruction mandibulaire par autotransplantation »
- 1 August 2020
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 48 (8) , 751-755
Use of an occlusal splint and intraoperative imaging with an intraoral approach in the management of mandibular subcondylar fractures
- 1 August 2020
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 48 (8) , 751-755
Use of an occlusal splint and intraoperative imaging with an intraoral approach in the management of mandibular subcondylar fractures
- 1 February 2020
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 65 (1) , 108-109
La couleur en face - (2e partie)
- 1 February 2020
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 65 (1) , 108-109
La couleur en face - (2e partie)
- Open Access
Likely Pathogenic Variants in One Third of Non-Syndromic Discontinuous Cleft Lip and Palate Patients
Oral clefts are composed of cleft of the lip, cleft of the lip and palate, or cleft of the palate, and they are associated with a wide range of expression and severity. When cleft of the palate is associated with cleft of the lip with preservation of the primary palate, it defines an atypical phenotype called discontinuous cleft. Although this phenotype may represent 5% of clefts of the lip and/or palate (CLP), it is rarely specifically referred to and its pathophysiology is unknown. We conducted whole exome sequencing (WES) and apply a candidate gene approach to non-syndromic discontinuous CLP individuals in order to identify genes and deleterious variants that could underlie this phenotype. We discovered loss-of-function variants in two out of the seven individuals, implicating FGFR1 and DLG1 genes, which represents almost one third of this cohort. Whole exome sequencing of clinically well-defined subgroups of CLP, such as discontinuous cleft, is a relevant approach to study CLP etiopathogenesis. It could facilitate more accurate clinical, epidemiological and fundamental research, ultimately resulting in better diagnosis and care of CLP patients. Non-syndromic discontinuous cleft lip and palate seems to have a strong genetic basis.
Open AccessLikely Pathogenic Variants in One Third of Non-Syndromic Discontinuous Cleft Lip and Palate Patients
Oral clefts are composed of cleft of the lip, cleft of the lip and palate, or cleft of the palate, and they are associated with a wide range of expression and severity. When cleft of the palate is associated with cleft of the lip with preservation of the primary palate, it defines an atypical phenotype called discontinuous cleft. Although this phenotype may represent 5% of clefts of the lip and/or palate (CLP), it is rarely specifically referred to and its pathophysiology is unknown. We conducted whole exome sequencing (WES) and apply a candidate gene approach to non-syndromic discontinuous CLP individuals in order to identify genes and deleterious variants that could underlie this phenotype. We discovered loss-of-function variants in two out of the seven individuals, implicating FGFR1 and DLG1 genes, which represents almost one third of this cohort. Whole exome sequencing of clinically well-defined subgroups of CLP, such as discontinuous cleft, is a relevant approach to study CLP etiopathogenesis. It could facilitate more accurate clinical, epidemiological and fundamental research, ultimately resulting in better diagnosis and care of CLP patients. Non-syndromic discontinuous cleft lip and palate seems to have a strong genetic basis.
- 1 August 2019
- Published by Springer Nature
- p. 845-854
Principles and Techniques for Facial Allotransplantation
- 1 August 2019
- Published by Springer Nature
- p. 845-854
Principles and Techniques for Facial Allotransplantation